Couturier et al. have sorted glioma stem cells into three categories, i.e., CD9+/CD133+, CD133−/CD24+/CD9−, and CD9+/CD44+/CD133− glioma cells based on single-cell RNA sequencing. This evidence concerns the gene PROM1 and central nervous system cancer.